CYduct Diagnostics, Inc. (CYDX)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -174.83 Thousand | -266.85 Thousand | -127.73 Thousand | -57.94 Thousand | -12.19 Thousand | -11.54 Thousand |
| Net Income | -418.03 Thousand | -472.74 Thousand | -420.49 Thousand | -372.03 Thousand | 559.05 Thousand | 1.91 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 243.2 Thousand | 205.88 Thousand | 292.75 Thousand | 252.58 Thousand | 238.1 Thousand | 274.98 Thousand |
| Other non-cash items | - | -22.2 Thousand | -293.43 Thousand | -191.08 Thousand | -1.04 Million | -2.47 Million |
| Investing Cash Flow | -191.00 | - | - | - | - | - |
| Investments in PPE | 3.00 | 4.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -191.00 | - | - | - | - | - |
| Financing Cash Flow | 150 Thousand | 50 Thousand | 380.5 Thousand | - | - | 32.49 Thousand |
| Debt repayment | -100 Thousand | -50 Thousand | -380.5 Thousand | - | - | -80 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 50 Thousand | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -47.5 Thousand |
| Accounts receivables | -1201.00 | -3907.00 | 21.28 Thousand | -17.9 Thousand | 10.8 Thousand | 27.5 Thousand |
| Accounts payables | 242.12 Thousand | 23.91 Thousand | 265.19 Thousand | 282.32 Thousand | 223.27 Thousand | 228.06 Thousand |
| Inventory | 2279.00 | 2196.00 | 6958.00 | -11.82 Thousand | 4022.00 | 19.41 Thousand |
| Other working capital | - | 183.68 Thousand | -680.00 | -1.00 | - | - |
| Cash at beginning of period | 54.82 Thousand | 271.68 Thousand | 18.91 Thousand | 18.36 Thousand | 30.56 Thousand | 9602.00 |
| Cash at end of period | 29.8 Thousand | 54.82 Thousand | 271.68 Thousand | 18.91 Thousand | 18.36 Thousand | 30.56 Thousand |
| Capital Expenditure | 3.00 | 4.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -25.02 Thousand | -216.85 Thousand | 252.76 Thousand | 553.00 | -12.19 Thousand | 20.95 Thousand |
| Free Cash Flow | -174.83 Thousand | -266.85 Thousand | -127.73 Thousand | -57.94 Thousand | -12.19 Thousand | -11.54 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -89.45 Thousand | -118.78 Thousand | -105.52 Thousand | -102.37 Thousand | -472.74 Thousand | -117.65 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 53.12 Thousand | 74.7 Thousand | 55.32 Thousand | 60.04 Thousand | 205.88 Thousand | 43.71 Thousand |
| Other non-cash items | - | -76.6 Thousand | -108.32 Thousand | -7047.00 | -22.2 Thousand | 139.28 Thousand |
| Investing Cash Flow | - | - | -191.00 | - | - | - |
| Investments in PPE | - | 1.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -191.00 | - | - | - |
| Financing Cash Flow | 50 Thousand | 50 Thousand | 50 Thousand | - | 50 Thousand | 50 Thousand |
| Debt repayment | -50 Thousand | -50 Thousand | - | - | -50 Thousand | -50 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 50 Thousand | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 2769.00 | -1781.00 | 581.00 | -2770.00 | -3907.00 | -4553.00 |
| Accounts payables | 48.9 Thousand | 79.34 Thousand | 106.72 Thousand | 7154.00 | 23.91 Thousand | -135.36 Thousand |
| Inventory | 1451.00 | -2859.00 | 1024.00 | 2663.00 | 2196.00 | 635.00 |
| Other working capital | - | - | -53 Thousand | 53 Thousand | 183.68 Thousand | 183 Thousand |
| Cash at beginning of period | 16.13 Thousand | 12.11 Thousand | 12.5 Thousand | 54.82 Thousand | 271.68 Thousand | 78.76 Thousand |
| Cash at end of period | 29.8 Thousand | 16.13 Thousand | 12.11 Thousand | 12.5 Thousand | 54.82 Thousand | 54.82 Thousand |
| Capital Expenditure | - | 1.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 13.67 Thousand | 4019.00 | -388.00 | -42.32 Thousand | -216.85 Thousand | -23.93 Thousand |
| Free Cash Flow | -36.33 Thousand | -45.98 Thousand | -50.19 Thousand | -42.32 Thousand | -266.85 Thousand | -73.93 Thousand |
BAC-PL
REVV
BEMO
CLIOINFO
HUBTOWN
0R6S